Athersys to Present at 2014 BIO Asia International Conference
March 26 2014 - 2:00PM
Athersys, Inc. (Nasdaq:ATHX) announced today that the Company will
present at the 2014 BIO Asia International Conference to be held at
the Grand Hyatt in Tokyo, Japan, from April 8-9, 2014.
Dr. Gil Van Bokkelen, Chairman and Chief Executive Officer, will
present on Wednesday, April 9, 2014 at 8:30 a.m. Japanese Standard
Time. Athersys is also a conference sponsor of the 2014 BIO Asia
International Conference.
About BIO Asia
The BIO Asia International Conference is an exclusive,
customized partnering forum that brings together U.S. and European
drug development companies with Asian biotech and pharmaceutical
companies interested in research collaborations and licensing
agreements. The format and selective nature of the conference makes
this the premier, dedicated biotech partnering event in Asia an
unrivalled opportunity to meet with the leading international
pharmaceutical and biotech companies in one place at one time. At
last year's event, over 300 delegates attended from 20
countries, representing more than 160 companies.
About Athersys
Athersys is a clinical stage biotechnology company engaged in
the discovery and development of therapeutic product candidates
designed to extend and enhance the quality of human life. The
Company is developing its MultiStem® cell therapy product, a
patented, adult-derived "off-the-shelf" stem cell product platform
for disease indications in the cardiovascular, neurological,
inflammatory and immune disease areas. The Company currently has
several clinical stage programs involving MultiStem, including for
treating inflammatory bowel disease, ischemic stroke, damage caused
by myocardial infarction, and for the prevention of
graft-versus-host disease. Athersys has also developed a diverse
portfolio that includes other technologies and product development
opportunities, and has forged strategic partnerships and
collaborations with leading pharmaceutical and biotechnology
companies, as well as world-renowned research institutions in the
United States and Europe to further develop its platform and
products.
CONTACT: William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
bjlehmann@athersys.com
Investor Relations:
Lisa M. Wilson
In-Site Communications
Tel: (917) 543-9932
lwilson@insitecony.com
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Apr 2023 to Apr 2024